The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers
Glioblastoma (GBM) is characterized by extensive cellular and genetic heterogeneity. Its initial presentation as primary disease (pGBM) has been subject to exhaustive molecular and …